Actinium Pharmaceuticals, Inc. (ATNM)
1.05
-0.05
(-4.55%)
USD |
NYAM |
Aug 24, 16:00
1.075
+0.02
(+2.38%)
Pre-Market: 08:12
Actinium Pharmaceuticals Price to Book Value : 1.090 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.090 |
| August 21, 2026 | 1.141 |
| August 20, 2026 | 1.162 |
| August 19, 2026 | 1.172 |
| August 18, 2026 | 1.121 |
| August 17, 2026 | 1.090 |
| August 14, 2026 | 1.079 |
| August 13, 2026 | 1.000 |
| August 12, 2026 | 0.852 |
| August 11, 2026 | 0.8229 |
| August 10, 2026 | 0.7992 |
| August 07, 2026 | 0.8274 |
| August 06, 2026 | 0.8166 |
| August 05, 2026 | 0.7769 |
| August 04, 2026 | 0.8405 |
| August 03, 2026 | 0.842 |
| July 31, 2026 | 0.8684 |
| July 30, 2026 | 0.8685 |
| July 29, 2026 | 0.8684 |
| July 28, 2026 | 0.8991 |
| July 27, 2026 | 0.8865 |
| July 24, 2026 | 0.8923 |
| July 23, 2026 | 0.9245 |
| July 22, 2026 | 0.9338 |
| July 21, 2026 | 0.9338 |
| Date | Value |
|---|---|
| July 20, 2026 | 0.9162 |
| July 17, 2026 | 0.9566 |
| July 16, 2026 | 0.9235 |
| July 15, 2026 | 0.9545 |
| July 14, 2026 | 0.9288 |
| July 13, 2026 | 0.939 |
| July 10, 2026 | 0.965 |
| July 09, 2026 | 1.006 |
| July 08, 2026 | 1.006 |
| July 07, 2026 | 1.090 |
| July 06, 2026 | 0.9971 |
| July 02, 2026 | 1.018 |
| July 01, 2026 | 1.017 |
| June 30, 2026 | 1.017 |
| June 29, 2026 | 13.48 |
| June 26, 2026 | 13.48 |
| June 25, 2026 | 12.94 |
| June 24, 2026 | 13.75 |
| June 23, 2026 | 13.89 |
| June 22, 2026 | 14.03 |
| June 18, 2026 | 14.03 |
| June 17, 2026 | 13.89 |
| June 16, 2026 | 13.35 |
| June 15, 2026 | 13.62 |
| June 12, 2026 | 13.75 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.906 |
| Alnylam Pharmaceuticals, Inc. | 23.31 |
| Anika Therapeutics, Inc. | 2.080 |
| Savara, Inc. | 7.949 |
| Vericel Corp. | 5.849 |
Price to Book Value Related Metrics
| PE Ratio | 2.944 |
| PS Ratio | 0.9354 |
| Price | 1.05 |
| Earnings Yield | 33.97% |
| Market Cap | 33.01M |
| Operating PE Ratio | 3.435 |
| Normalized PE Ratio | 2.944 |